Although the clinical efficacy of implantable cardioverter-defibrillators (ICDs) has been
convincingly demonstrated in clinical trials, the impact of ICDs on health care costs and …

Background Patients with left ventricular systolic dysfunction (LVSD) are at high risk of
sudden cardiac death (SCD). Implantable cardioverter defibrillators (ICDs) have an …

Importance Conflicting data have emerged on the efficacy of implantable cardioverter
defibrillators (ICDs) for primary prevention of sudden cardiac death (primary prevention …

Results from the DANISH Study (Danish Study to Assess the Efficacy of ICDs in Patients
With Non-Ischemic Systolic Heat Failure on Mortality) suggest that for many patients with …

Published randomized controlled trials present convincing evidence that implantable
cardioverter-defibrillators (ICDs) are effective for primary and secondary prevention of …

Background—Patients with resuscitated ventricular tachyarrhythmias (ventricular
tachycardia/ventricular fibrillation) benefit from implantable cardioverter-defibrillators (ICDs) …

Although improved patient survival has been reported in several randomized trials with the
implanted cardioverter-defibrillator,< 15% of patients treated with defibrillators during trials …

The Multicenter Automatic Defibrillator Implantation Trial II demonstrated a significant 31%
reduction in the risk of mortality in postinfarction patients with low ejection fraction (EF≤ …

Background Three randomized clinical trials showed that implantable cardioverter-
defibrillators (ICDs) reduce the risk of death in survivors of ventricular tachyarrhythmias, but …

Objectives: The aim of this study was to determine if the benefit of implantable cardioverter-
defibrillators (ICDs) is modulated by medical comorbidity. Background: Primary prevention …